ANE is a leading express freight network in China’s less-than-truckload (“LTL”) market. As of December 31, 2024, ANE had 82 self-operated sorting centres across China, covering approximately 99.3% of the counties and townships.

The company mainly provides transportation services, value-added services and dispatch services to its freight partners, its direct customers. Together with its freight partners and agents, ANE served over 6.3 million shippers, its end-customers, across China as of December 31, 2024.

Arion is a private tertiary cancer hospital in Beijing, jointly founded and invested by Amcare Group, Centurium Capital and other financial/strategic investors. Dedicated to personalized full-cycle cancer treatments and management, from prevention and early test of symptoms, to adoption of most advanced cancer treatment methods, the hospital brings globally-leading treatment skills, concept and talents to cancer patients in China.

Located in Daxing District in South Beijing, Arion Cancer Hospital covers an area of over 24,000 square meters with 400 beds for inpatients, including 60 day-time beds for chemotherapy and 24 ICU/emergency beds.

Fadada is a leading e-signature and cloud contract service provider in China. The company offers a full suite of e-signature products including one-stop SaaS products, open API solutions for corporate IT and ERP systems, as well as hybrid cloud solutions for local hosting of electronic contracts and process management.

Fadada is a pioneer in legal technology innovation. It was the earliest provider of block-chain based e-signature product with enhanced security features and credibility. It pioneered in building an industry-leading e-contract management system, which significantly improved the efficiency of the legal process involved in contract signing. It was the first to enable online data sharing and connection with judiciary bodies, including online arbitration institutions, online courtroom, notary offices and forensic evaluation centers, providing one of the most complete technology solutions for online dispute resolutions in China.

Fadada’s products are ISO27001 and ISO27018 accredited and its clients include leading Chinese and global corporates such as Tencent, Microsoft (China), Bytedance, Alibaba, Oracle, Meituan, Ctrip, Yuexiu Real Estate, Poly Real Estate, Xugong Group, Fesco, China Telecom, Haidilao, New Oriental Education and Xiao Hong Shu.

Founded in 2013, Gaussian Robotics is a technology driven company focusing on SLAM (“Simultaneous Localization And Mapping”) application and development. Gaussian Robotics is a pioneer and leader in the enterprise-level AMR (“autonomous mobile robots”) cleaning robotics space with six key products covering seven major cleaning functions.

Gaussian Robotics is the only cleaning robotics company with ISO9001, Chinese robotics CR, U.S. UL safety and Europe CE safety certificates. Up to date, Gaussian Robotics has provided services to more than 2,000 customers globally, equivalent of over 200 million kilometers of cleaning distance.  

Driven by self-developed AMR technologies applicable for all scenarios and full stack, Gaussian Robotics offers integrated manufacturing, research, development, sales and services to its customers. Gaussian Robotics is committed to transform the traditional services industry into the new era of intelligent services powered by robotics technology.

GOUMEE is a tech-driven online brand operation and marketing service provider in fashion industry. It focuses on live-streaming e-commerce operation and influencer marketing, helping brands to acquire customers in new traffic channels and developing new products. GOUMEE is a first-tier live-streaming e-commerce Douyin Partner and a top notch service provider in both T-mall and Douyin.

Shanghai Innogen Pharmaceutical Technology Co., Ltd.  is a science-driven biotechnology company dedicated to the research and development of innovative and affordable medicines for diabetes and other metabolic disease patients. Innogen’s pipeline in metabolic disease, including Type 1 & 2 diabetes, obesity and NASH, is independently developed and has global market rights.

Supaglutide, the company’s first pipeline product, Efsubaglutide Alfa (previously named as Supaglutide, with trade name: DiabegoneTM ), was approved by the NMPA in January, 2025. It is the first humanized long-acting GLP-1 drug that originated from China, which will benefit more diabetes patients. Other indications for Efsubaglutide Alfa such as obesity and MASH are also under development to address the large unmet therapeutic needs in these disease areas.

Kidswant is a leading mother-infant-children (MIC) service brand and retailer in China providing family products and services. Through its mega stores and online e-commerce platforms, Kidswant services millions of Chinese families. The company differentiates itself with its large team of professional children nurturing consultants, who provide real-time and personalized counsel to customers.

Founded in 2019, Kidswant provides one-stop services to expectant mothers and 0-14 year-old children, driven by its strong customer relationship management system. Committed to continuous improvement of children’s growth and living standards, Kidswant has become one of the top service providers for China’s new families.

Suzhou LASO Biotech is the first company in China for the proprietary development, production, and commercialization of microarray technology platform, providing an integrated solution including chips (customizable), the OmniScan device, reagents, softwares and algorithms.

As of now, Laso Biotech has obtained 13 invention patents, 5 utility model patents, 3 design patents, and 1 medical device registration certificate, making it the company with the most comprehensive intellectual property portfolio and independently controllable core technologies for microarray under Chinese law.

Founded in 2011 in Shenzhen, China, LOHO is the first O2O fashion glasses retail platform in China. The M2C mode firstly launched by LOHO has broken the industrial monopoly and created a mode that directly connects manufacturing to end-user. It cuts the cost of intermediate links and gains an absolute advantage in cost and price.

The LOHO platform provides updates on a daily basis, offering products with various designs and SKU to meet the needs of different consumer groups and scenarios.

The LOHO products are designed by world’s first class brand designers, and is committed to bring young consumers highly cost-effective and stylish glasses and experiences. LOHO has had several hundreds of stores nationwide in China, covering core business areas in more than 100 cities including Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing, Chongqing, Chengdu and Changsha.

Luckin Coffee (OTC: LKNCY) is the pioneer of a technology-driven new retail model to provide coffee and other products of high quality, high affordability, and high convenience to customers. Its mission is to be part of everyone’s everyday life, starting with coffee. As of March 31, 2025, Luckin operates 24,097 stores in China and Singapore.

Luckin’s online-offline model is built upon its mobile and store networks. Its mobile app and presence on other third-party platforms cover the entire customer purchase process, offering customers a 100% cashier-less environment. This enhances its customer experience, improves its operating efficiency, and allows it to stay connected with customers and engage with them anytime, anywhere. Luckin’s store network is comprised of pick-up stores, relax stores, and delivery kitchens, which enable the company to maximize convenience for its customers, improve its brand recognition, and achieve broader delivery coverage.

Luckin Coffee was founded in 2017 and is based in Xiamen, China.

Founded in 2011, Meican is China’s largest group catering solutions provider. The Company offers comprehensive catering solutions to corporate clients and their employees, including both on-premise and off-premise catering and SaaS solutions. It also offers SaaS solutions to traditional group dining players, including digital ordering, integrated payment processing, catering operation, corporate fee control, as well as reporting & analytics.

Mitrassist is a leading angiocarpy treatment devices platform with globally cutting-edge innovation. It has introduced a minimally invasive approach to Mitral Regurgitation (MR) treatment that is neither repair nor replacement. The company’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients.

NTX™ revolutionized the textile industry by introducing NTX™ Cooltrans™, a breakthrough waterless dyeing & printing system that delivers up to 90% in water savings, alongside dramatic reduction in energy usage and virtual elimination of water waste. With NTX™ Cooltrans™ as a foundation, the company has established a Southeast Asia-based ecosystem of textile processing plants to become the next generation sustainable eco- friendly supply chain partner for some of the world’s biggest fashion and apparel brands. NTX™ functions as a complete environmentally friendly textile processing solution provider by putting in place best practices, technical expertise, staff training, raw material sourcing and market opportunities across its ecosystem.

PhiSkin is a leading aesthetic medical clinic chain targeting mid-to-high-end customers in Beijing, Shanghai and other top tier cities in China. PhiSkin was founded in 2012 and is headquartered in Shanghai. As of today, PhiSkin has six clinics in operation across four cities – three in Shanghai, and one each in Beijing, Hangzhou, and Ningbo.

Instead of traditional plastic surgeries which typically require higher cost and a longer recovery period, Phiskin practices non- and minimal invasive treatments, notably thread lift, lower eyelid blepharoplasty and small-volume liposuction.

Qlife is a biomedical company developing high throughput mass spectrometry technology, which is fully Qlife is a biomedical company developing high throughput mass spectrometry technology, which is fully incorporated into omics study to drive for innovative medical laboratory tests and diagnosis. With headquarters in Shanghai and five regional laboratory service centers strategically located in China, Qlife offers innovative metabolomics/proteomics-based assays and laboratory diagnostic tests to enable early prevention and intervention of a variety of diseases. The R&D of Qlife is at the heart of the emerging fields of metabolomics and proteomics. Its proprietary platform and exclusive bioinformatics solutions are at the frontiers to deliver biomarker discoveries and innovative diagnostic tests, as well as aiming to make breakthroughs in precision medicine.

Ruhlamat Group was founded in Germany and established its China headquarters in Suzhou in 1998. Over the past two decades since its inception, Ruhlamat Group has developed a global presence with operations with nine production centers, two technical service centers in Romania, the Czech Republic, India, Mexico and China. Ruhlamat was acquired by Centurium Capital in 2025. 

Ruhlamat’s business covers automation solutions, digital solutions, and standard products (servo presses, conveyor systems, and industrial aluminum profiles). Integrating the entire process of process R&D, design, assembly, testing, sales, and service, it provides end-to-end solutions for clients in traditional automotive parts, new energy vehicle components, hydrogen energy, medical and consumer electronics, home appliances, and other general industrial sectors in over 20 countries and regions across Europe, the Americas, and Asia-Pacific.

Seyond™, formerly Innovusion, is defined by devotion to its mission — to design, build, and mass produce the world’s highest-performing state-of-the-art LiDAR systems.

Headquartered in Silicon Valley, with additional facilities in Suzhou and Shanghai, Seyond represents the vanguard in long-range image-grade LiDAR and autonomous driving. Seyond’s technologies are enthusiastically embraced across automotive, smart transportation, rail transit, and industrial automation by industry leaders across the world.

Sinotau Pharmaceutical is an innovative pharmaceutical company focusing on the R&D, production and clinical application of a new generation of radiopharmaceuticals. Headquartered in Beijing, the company has set up radiopharmaceutical production bases in Jiangsu, Guangdong and Sichuan, and branches in the United States. Leveraging the world’s leading R&D resources in the field of radiopharmaceuticals and precision diagnosis and treatment, Sinotau has taken the lead in deploying a variety of targeted therapies and precision diagnostic radiopharmaceuticals in the fields of tumors, neurodegenerative diseases and cardiovascular diseases. The company’s pipeline has deployed multiple radiological diagnostic and therapeutic products, some of which have entered the stage of registered clinical research.

Taibang Biologic Group is a leading fully integrated plasma-based biopharmaceutical company in China. The company’s core capabilities include plasma collection, and the manufacturing and commercialization of human plasma-based biopharmaceutical products. These products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. As the company focuses on its plasma business, Taibang have expanded its product pipeline to include non-plasma biopharmaceutical products and bio-medical device products to complement its market position and expand its base of users in the growing core plasma therapeutic business.

UIB Healthcare Group is a leading pediatrics healthcare services provider with a primary focus in top-tier cities in China. The group currently owns and operates a number of hospitals and facilities in Beijing and Shanghai, including Beijing Jingdu Children’s Hospital, Shanghai Pubin Children’s Hospital and UIB International Maternity Care Center. With annual number of outpatient visits of 800,000 person-times, the group is one of the largest private hospital groups in China.

UIB Healthcare strives for the highest medical treatment standards and professional integrity, and takes pride in its highly-skilled medical team. Its facilities are leaders in treatment of specialties such as hematology, gastroenterology, cardiac surgery and children developmental behavior. For example, Beijing Jingdu Children’s Hospital has China’s largest hematology department and transplantation center.

Through continuous academic advancement across its core departments and improving its service quality, UIB Healthcare strives to become a first-class women’s and children’s healthcare brand in China, as well as a preferred platform for healthcare practitioners.

XPENG is a leading Chinese Smart EV company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to drive Smart EV transformation with technology, shaping the mobility experience of the future. In order to optimize its customers’ mobility experience, XPENG develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture.

XPENG is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Silicon Valley, San Diego and Amsterdam. The Company’s Smart EVs are mainly manufactured at its plants in Zhaoqing and Guangzhou, Guangdong province.

Yigoli is China’s first and leading AI-enabled high-tech car wash solution provider with over 3,000 car wash outlets covering most provinces in China, South Korea, Thailand and Indonesia. Leveraging its self-developed intelligent operation system, Yigoli offers one of the most efficient and environmentally- friendly car wash services for customers in China and abroad.

Yunxuetang is a leading corporate training SaaS and services provider in China. Founded in 2011, Yunxuetang provides one-stop training solutions including SaaS, content development and services to thousands of big corporate clients and nearly 30,000 SMEs, including Fortune 500 companies, Tongrentang, Haidilao, Didi, Luckin Coffee and NIO. Headquartered in Beijing and Suzhou, the company has branch offices in over 20 Chinese cities including Shenzhen and Hangzhou.

Yunxuetang’s total solutions include training infrastructure establishment, training materials development, training program maintenance, data analysis and vendor management to meet increasing demands for more efficient staff training as Chinese companies grow and evolve.